• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厄洛替尼相关的睫毛粗长症。

Erlotinib-associated trichomegaly.

作者信息

Lane Katherine, Goldstein Scott M

机构信息

Oculoplastic Service, Wills Eye Hospital, Jefferson University Hospital Center, Philadelphia, Pennsylvania 19107, USA.

出版信息

Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb;23(1):65-6. doi: 10.1097/IOP.0b013e31802d9802.

DOI:10.1097/IOP.0b013e31802d9802
PMID:17237698
Abstract

A 70-year-old woman presented with a corneal ulcer resulting from aberrant and exuberant eyelash growth. She had recently been diagnosed with recurrent non-small-cell lung cancer for which she had begun a chemotherapeutic regimen that included erlotinib HCl. After several months of treatment, she noted the onset of escalating ocular irritation, which culminated in her presentation. Examination of her ocular adnexa revealed coarse, brittle, irregular aberrant eyelash growth. She has been successfully treated with regular epilation and eyelash trimming and has remained symptom free.

摘要

一名70岁女性因睫毛异常旺盛生长导致角膜溃疡前来就诊。她最近被诊断出患有复发性非小细胞肺癌,并已开始接受包含盐酸厄洛替尼的化疗方案。经过几个月的治疗,她注意到眼部刺激症状不断加重,最终前来就诊。眼部附属器检查发现睫毛生长异常,粗糙、易脆且不规则。她通过定期拔毛和修剪睫毛得到了成功治疗,至今仍无症状。

相似文献

1
Erlotinib-associated trichomegaly.厄洛替尼相关的睫毛粗长症。
Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb;23(1):65-6. doi: 10.1097/IOP.0b013e31802d9802.
2
Trichomegaly induced by erlotinib.厄洛替尼引起的睫毛过长。
Orbit. 2008;27(4):329-30. doi: 10.1080/01676830802222936.
3
Trichomegaly secondary to erlotinib.厄洛替尼所致的睫毛粗长症。
Can J Ophthalmol. 2009 Dec;44(6):e65. doi: 10.3129/i09-158.
4
Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.接受表皮生长因子受体抑制剂厄洛替尼治疗的患者出现面部多毛症和睫毛粗长。
J Am Acad Dermatol. 2010 Aug;63(2):e56-8. doi: 10.1016/j.jaad.2009.11.589.
5
Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.厄洛替尼引起的眼部副作用及睫毛粗长症:一例报告并文献复习
Cont Lens Anterior Eye. 2015 Feb;38(1):59-60. doi: 10.1016/j.clae.2014.08.005. Epub 2014 Sep 22.
6
Acquired trichomegaly: trichomegaly secondary to erlotinib.获得性睫毛粗长症:继发于厄洛替尼的睫毛粗长症。
JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545.
7
Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.厄洛替尼治疗非小细胞肺癌时出现的三联征:多毛症、脱发和男性型毛发过度生长。
Ir J Med Sci. 2011 Mar;180(1):283-4. doi: 10.1007/s11845-009-0458-6. Epub 2010 Jan 28.
8
A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).一例由厄洛替尼(特罗凯)引起的睫毛粗长和面部多毛症病例。
Int J Dermatol. 2009 Jan;48(1):97-8. doi: 10.1111/j.1365-4632.2009.03752.x.
9
Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.厄洛替尼诱发一名男性胰腺癌患者出现睫毛粗长症。
Cutan Ocul Toxicol. 2010 Mar;29(1):62-6. doi: 10.3109/15569520903440058.
10
Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.肺癌患者使用表皮生长因子受体抑制剂厄洛替尼治疗后出现睫毛粗长症。
J Clin Oncol. 2008 Jul 10;26(20):3460-2. doi: 10.1200/JCO.2008.16.9391.

引用本文的文献

1
Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues.评估酪氨酸激酶抑制剂与前列腺素类似物所致巨毛症的临床和形态学特征。
PLoS One. 2024 Dec 31;19(12):e0313326. doi: 10.1371/journal.pone.0313326. eCollection 2024.
2
Erlotinib-induced dry eye.厄洛替尼引起的干眼症。
Indian J Ophthalmol. 2023 Apr;71(4):1657-1658. doi: 10.4103/IJO.IJO_2582_22.
3
Ocular Toxicity of Targeted Anticancer Agents.靶向抗癌药物的眼部毒性。
Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.
4
Cicatricial ectropion and madarosis associated with panitumumab treatment of metastatic colorectal cancer.与帕尼单抗治疗转移性结直肠癌相关的瘢痕性睑外翻和睫毛脱落
Am J Ophthalmol Case Rep. 2020 Jun 30;19:100810. doi: 10.1016/j.ajoc.2020.100810. eCollection 2020 Sep.
5
A murine model of dry eye induced by topical administration of erlotinib eye drops.局部滴注厄洛替尼滴眼液诱导的干眼小鼠模型。
Int J Mol Med. 2018 Mar;41(3):1427-1436. doi: 10.3892/ijmm.2017.3353. Epub 2017 Dec 29.
6
Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review.厄洛替尼治疗肺腺癌患者后出现的睫毛异常增长及头皮毛发改变:一例报告及文献综述
Exp Ther Med. 2016 Sep;12(3):1287-1292. doi: 10.3892/etm.2016.3460. Epub 2016 Jun 16.
7
Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.一名非小细胞肺癌患者接受厄洛替尼治疗后出现睫毛粗长症:病例报告及文献综述
Oncol Lett. 2015 Aug;10(2):954-956. doi: 10.3892/ol.2015.3265. Epub 2015 May 26.
8
Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas.针对局部晚期眼睑及眼周癌的表皮生长因子受体(EGFR)和音猬因子(sonic hedgehog)信号通路
World J Clin Cases. 2014 Sep 16;2(9):432-8. doi: 10.12998/wjcc.v2.i9.432.
9
Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas.胰腺癌患者使用厄洛替尼治疗后出现睫毛粗长症。
Int J Trichology. 2014 Jan;6(1):23-4. doi: 10.4103/0974-7753.136755.
10
Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma.眶周和眼周基底细胞癌和鳞状细胞癌的靶向治疗。
Ophthalmic Plast Reconstr Surg. 2013 Mar-Apr;29(2):87-92. doi: 10.1097/IOP.0b013e3182831bf3.